insomnia

FDA approves new type of drug for insomnia

On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor antagonist. Read more
UTIs

Study: Insomnia may increase mortality

A study in Circulation reports that some insomnia symptoms (difficulty initiating asleep and nonrestorative sleep) are associated with a modestly higher risk of mortality. Read more.

FDA approves new type of drug for insomnia

On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor…
UTIs

Study: Insomnia may increase mortality

A study in Circulation reports that some insomnia symptoms (difficulty initiating asleep and nonrestorative sleep) are associated with a modestly higher risk of mortality.…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Test Your Knowledge

Which of the following best describes Wegovy’s FDA-approved use?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.